New Formulation Rebif for Relapsing Multiple Sclerosis Lowers Immunogenicity and Improves Tolerability: Presented at ECTRIMS
MADRID, SPAIN –
September 30, 2006 –
At ... more »
|
|||||
|
Multiple Sclerosis Info
Search
This Month
|
Sunday, October 1
Oral drug, Fingolimod, phase 2 study
by
All About MS
on Sun 01 Oct 2006 03:09 PM CST
Oral FTY720 (Fingolimod) for Relapsing Multiple Sclerosis Shows Sustained Benefits for Up to 2 Years: Presented at ECTRIMS By Bruce Sylvester MADRID, SPAIN ... more » |
||||